Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03582956 · ClinicalTrials.gov registry record · NA
Effect of Adiposity on Hepatic and Peripheral Insulin Resistance in Type 1 Diabetes
A NA study, sponsored by Yale University.
- Terminated
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT03582956 is a NA study that was terminated before completion, run by Yale University. The registered enrollment target is 23 participants.
The verdict
NCT03582956, a NA study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effects of adiposity on resistance to insulin's ability to suppress hepatic glucose production and to stimulate peripheral glucose metabolism in adolescents with type 1 diabetes. In addition, this study will also examine the role of fatty liver disease on the insulin resistance of obesity in adolescents with type 1 diabetes.
Interventions
- PROCEDURE Euglycemic hyperinsulinemic clamp with tracer enhancement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2022-08-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03582956
The ClinicalTrials.gov registry entry for NCT03582956 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Euglycemic hyperinsulinemic clamp with tracer enhancement is the first listed.
NCT03582956 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03582956 about?
NCT03582956 is a clinical study titled "Effect of Adiposity on Hepatic and Peripheral Insulin Resistance in Type 1 Diabetes". The purpose of this study is to assess the effects of adiposity on resistance to insulin's ability to suppress hepatic glucose production and to stimulate peripheral glucose metabolism in adolescents with type 1 diabetes. In addition, this study will also examine the role of fatty liver disease on t...
What is the current status of trial NCT03582956?
This trial is currently terminated. It is a NA study. The enrollment target is 23 participants. The study started on 2019-01-01. Estimated completion is 2022-08-12.
What interventions are being tested in trial NCT03582956?
The interventions under investigation include: Euglycemic hyperinsulinemic clamp with tracer enhancement (PROCEDURE).
Who is sponsoring clinical trial NCT03582956?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.